Computational approaches for modeling human intestinal absorption and permeability

Journal of Molecular Modeling

Volumn 12, Issue 5, 2006, Pages 577-589

  Subramanian, Govindan ^a,b   Kitchen, Douglas B ^a  

^a ALBANY MOLECULAR RESEARCH INC   (United States)

^b Transtech Pharma   (United States)

Author keywords

ADME; Caco 2 permeability; Human intestinal absorption; QSAR; QSPR

Indexed keywords

ACICLOVIR; ALPRENOLOL; BETAXOLOL; CHLORAMPHENICOL; CLONIDINE; DESIPRAMINE; DOXORUBICIN; FLEROXACIN; FLUCONAZOLE; GUANOXAN; HYDROCORTISONE; IBUPROFEN; IMIPRAMINE; LISINOPRIL; MIBEFRADIL; NALOXONE; NAPROXEN; OXPRENOLOL; PENICILLIN G; PINDOLOL; PRACTOLOL; PROPRANOLOL; SULPIRIDE; SUMATRIPTAN; TENIDAP; THEOPHYLLINE; TIACRILAST; TIMOLOL; UNINDEXED DRUG; ZIPRASIDONE;

ARTICLE; CALCULATION; CONTROLLED STUDY; DRUG ABSORPTION; IN VIVO STUDY; INTERMETHOD COMPARISON; INTESTINE ABSORPTION; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; MEDICAL LITERATURE; PREDICTION; PRIORITY JOURNAL; PROCESS MODEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL MODEL; TRAINING;

CACO-2 CELLS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; HUMANS; INTESTINAL ABSORPTION; PERMEABILITY;

EID: 33746461831     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-005-0065-z     Document Type: Article

References (55)

1. Smith DA, van de Waterbeemd H (1999) Curr Opin Chem Biol 3:373-378
2. Clark DE, Pickett SD (2000) Drug Discovery Today 5:49-58
3. Fecik RA, Frank KE, Gentry EJ, Menon SR, Mitscher LA, Telikepalli H (1998) Med Res Rev 18:149-185
4. Tarbit MH, Berman J (1998) Curr Opin Chem Biol 2:411-416
5. Navia MA, Chaturvedi PR (1996) Drug Discovery Today 1:179-189
6. Chan OH, Stewart BH (1996) Drug Discovery Today 1:461-473
7. Tsuji A, Tamai I (1996) Pharm Res 13:963-977
8. Lin JH, Lu AYH (1997) Pharmacol Rev 49:403-449
9. Stewart BH, Chan OH, Lu RH, Reyner EL, Schmid HL, Hamilton HW, Steinbaugh BA, Taylor MD (1995) Pharm Res 12:693-699
10. Stewart BH, Chan OH, Jezyk N, Fleisher D (1997) Advanced Drug Delivery Reviews 23:27-45
11. Barthe L, Woodley J, Houin G (1999) Fundam Clin Pharm 13:154-168
12. Pinto M, Robine-Leon S, Appay M-D, Kedinger M, Triadou N, Dussaulx E, LaCroix B, Simon-Assmann P, Haffen K, Fogh J, Zweibaum A (1983) Biol Cell 47:323-330
13. Hidalgo IJ, Raub TJ, Borchardt RT (1989) Gastroenterology 96:736-749
14. Wilson G, Hassan IF, Dix CJ, Williamson I, Shah R, Mackay M (1990) J Controlled Release 11:25-40
15. Delie F, Rubas WA (1997) Crit Rev Ther Drug Carrier Syst 14:221-286
16. Artursson P, Karlsson J (1991) Biochem Biophy Res Commun 175:880-885
17. Palm K, Luthman K, Ungell A-L, Strandlund G, Artursson P (1996) J Pharm Sci 85:32-39
18. Rubas W, Cromwell MEM (1997) Advanced Drug Delivery Rev 23:157-162
19. Yee S (1997) Pharm Res 14:763-766
20. Lennernäs H (1998) J Pharm Sci 87:403-410
21. Grès M-C, Julian B, Bourré M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G (1998) Pharm Res 15:726-733
22. Krarup LH, Christensen IT, Hovgaard L, Frokjaer S (1998) Pharm Res 15:972-978
23. Palm K, Luthman K, Ungell A-L, Strandlund G, Beigi F, Lundahl P, Artursson P (1998) J Med Chem 41:5382-5392
24. Martin YC (1981) J Med Chem 24:229-237
25. Nook T, Doelker E, Buri P (1988) Int J Pharmaceut 43:119-129
26. Merino V, Freixas J, Val Bermejo MD, Garrigues TM, Moreno J, Plá-Delfina JM (1995) J Pharm Sci 84:777-782
27. Camenisch G, Folkers G, van de Waterbeemd H (1996) Pharmaceutica Acta Helvetiae 71:309-327
28. Testa B, Carrupt P-A, Gaillard P, Billois F, Weber P (1996) Pharm Res 11:335-343
29. Camenisch G, Folkers G, van de Waterbeemd H (1998) Eur J Pharm Sci 6:325-333
30. Camenisch G, Alsenz J, van de Waterbeemd H, Folkers G (1998) Europ J Pharm Sci 6:313-319
31. Lipinski CA, Christopher AL (1997) Advanced Drug Delivery Rev 23:3-25
32. Clark DE (1999) J Pharmaceutical Sci 88:807-814
33. Sugawara M, Takekuma Y, Yamada H, Kobayashi M, Iseki K, Miyazaki K (1998) J Pharmaceutical Sci 87:960-966
34. Winiwarter S, Bonham NM, Ax F, Hallberg A, Lennernäs H, Karlén A (1998) J Med Chem 41:4939-4949
35. Bermejo M, Merino V, Garrigues TM, Plá-Delfina JM, Mulet A, Vizet P, Trouiller G, Mercier C (1999) J Pharm Sci 88:398-405
36. van de Waterbeemd H, Camenisch G (1996) Quant Struct Act Relat 15:480-490
37. Palm K, Stenberg P, Luthman K, Artursson P (1997) Pharm Res 14:568-571
38. Stenberg P, Luthman K, Artursson P (1999) Pharm Res 16:205-212
39. Goodwin JT, Mao B, Vidmar TJ, Conradi RA, Burton PS (1999) J Peptide Res 53:355-369
40. Norinder U, Österberg T, Artursson P (1999) European J Pharm Sci 8:49-56
41. Ghuloum AM, Sage CR, Jain AN (1999) J Med Chem 42:1739-1748
42. Wessel MD, Jurs PC, Tolan JW, Muskal SM (1998) J Chem Inf Comp Sci 38:726-735
43. Irvine JD, Takahashi L, Lockhart K, Cheong J, Tolan JW, Selick HE, Grove JR (1999) J Pharm Sci 88:28-33
44. Kansy M, Senner F, Gubernator K (1998) J Med Chem 41:1007-1010
45. Pade V, Stavchansky S (1998) J Pharmaceutical Sci 87:1604-1607
46. Rappe AK, Casewit CJ, Colwell KS, Goddard WA, Skiff WM (1992) J Am Chem Soc 114:10024-10035
47. The PSA arising from the oxygen, nitrogen, and halogen atoms, and the -OH, -NH2 groups was calculated using the solvent accessible surface area in Cerius2 with the van der Waals radii reported in reference 37.
48. Herman RA, Veng-Pedersen P (1994) J Pharm Sci 83:423-428
49. Rogers D, Hopfinger AJ (1994) J Chem Inf Comp Sci 34:854-866
50. Genetic partial least squares in QSAR: Rogers D (1996) In: Devillers J (ed) Genetic algorithms in molecular modeling. Academic, London
51. Stanton DT, Jurs PC (1990) Anal Chem 62:2323-2329
52. Hall LH, Kier LB, Brown BB (1995) J Chem Inf Comp Sci 35:1074-1080
53. Viswanadham VN, Ghose AK, Revankar GR, Robins RK (1989) J Chem Inf Comput Sci 29:163-172
54. Norinder U, Österberg T, Artursson P (1997) Pharm Res 14:1786-1791
55. Stewart BH, Chung FY, Tait B, Blankley CJ, Chan OH, John C (1998) Pharm Res 15:1401-1406